| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Bottom-up Approach for Mutant and Wild Type Collies Using Physiologically Based Pharmacokinetic (PBPK) Modeling: A Case Study Using Loperamide
|
Cross, Charlotte
|
|
|
27 |
4 |
|
article
|
| 2 |
A Comparative Study on Physicochemical and Analytical Characterizations of Doxil® and its Generic Drug Products
|
Eneli, Adaeze
|
|
|
27 |
4 |
|
article
|
| 3 |
An Ocular Exposure Prediction for Topical Atropine in Human Using Physiologically Based Pharmacokinetic Modeling
|
Zheng, Aole
|
|
|
27 |
4 |
|
article
|
| 4 |
Application of Real-World Evidence to Support FDA Regulatory Decision Making
|
Khaowroongrueng, Vipada
|
|
|
27 |
4 |
|
article
|
| 5 |
Assessing the Impact of Multiple Imputation Algorithms on Pharmacokinetic Model Performance: A Simulation-Based Study
|
Duflot, Thomas
|
|
|
27 |
4 |
|
article
|
| 6 |
Automation of Anti-Drug Antibody Enrichment Using Streptavidin PhyTip® Columns for Sample Pretreatment in an Immunogenicity Assay
|
Luong, Michael
|
|
|
27 |
4 |
|
article
|
| 7 |
Correction: Establishing Clinically Relevant Specifications for Carbamazepine Tablets Using Physiologically Based Pharmacokinetic Modeling
|
Wang, Xiaofeng
|
|
|
27 |
4 |
|
article
|
| 8 |
Correction: Nitrosamines Risk Assessment for Biopharmaceutics Classifcation System Class IV Molecule Containing Immediate Release Products: Use of In-Silico Prediction Tools and Physiologically Based Pharmacokinetic Modeling
|
Kollipara, Sivacharan
|
|
|
27 |
4 |
|
article
|
| 9 |
Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic Modeling
|
Bucher, Ronald W.
|
|
|
27 |
4 |
|
article
|
| 10 |
Establishing Clinically Relevant Specifications for Carbamazepine Tablets Using Physiologically Based Pharmacokinetic Modeling
|
Wang, Xiaofeng
|
|
|
27 |
4 |
|
article
|
| 11 |
Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review
|
Mao, Bingyu
|
|
|
27 |
4 |
|
article
|
| 12 |
Factors Impacting the Immunogenicity of Etrolizumab & Clinical Consequences
|
Sperinde, Gizette
|
|
|
27 |
4 |
|
article
|
| 13 |
Generating Realistic Albumin Concentrations in Virtual Subjects Across A Spectrum of Renal Function to Account for Variability in Protein Binding Within PBPK Models
|
Hu, Yuming
|
|
|
27 |
4 |
|
article
|
| 14 |
IFN-γ/IL-2 Double-Color FluoroSpot Assay for Monitoring Human Primary T Cell Activation: Validation, Inter-Laboratory Comparison, and Recommendations for Clinical Studies
|
Mauthe, Alexandra
|
|
|
27 |
4 |
|
article
|
| 15 |
Improvement of Drug Release from an Aptamer Drug Conjugate Using Reductive-sensitive Linkers for Tumor-targeted Drug Delivery
|
Wu, You
|
|
|
27 |
4 |
|
article
|
| 16 |
Improving the Therapeutic Selectivity of Trastuzumab Deruxtecan Using 8C2 Fab Fragments
|
Gong, Jue
|
|
|
27 |
4 |
|
article
|
| 17 |
Investigations of Influence of Antibody Binding Kinetics on Tumor Distribution and Anti-Tumor Efficacy
|
Chen, Ping
|
|
|
27 |
4 |
|
article
|
| 18 |
Model-informed Drug Development (MIDD) Approach to Support Biopharmaceutical Development of Iberdomide
|
Sychterz, Caroline
|
|
|
27 |
4 |
|
article
|
| 19 |
Model-Informed Immunogenicity Assessment of Nivolumab as Monotherapy and in Combination with Ipilimumab
|
Zhao, Yue
|
|
|
27 |
4 |
|
article
|
| 20 |
Nitrosamines Risk Assessment for Biopharmaceutics Classification System Class IV Molecule Containing Immediate Release Products: Use of In-Silico Prediction Tools and Physiologically Based Pharmacokinetic Modeling
|
Kollipara, Sivacharan
|
|
|
27 |
4 |
|
article
|
| 21 |
Physiologically Based Modeling of Cefoxitin, Cefazolin, and Piperacillin Pharmacokinetics in Obese and Lean Rats
|
Sheng, Yi-Hua
|
|
|
27 |
4 |
|
article
|
| 22 |
Publisher Correction: Generating Realistic Albumin Concentrations in Virtual Subjects Across A Spectrum of Renal Function to Account for Variability in Protein Binding Within PBPK Models
|
Hu, Yuming
|
|
|
27 |
4 |
|
article
|
| 23 |
Publisher Correction: Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study Data
|
Cleary, Yumi
|
|
|
27 |
4 |
|
article
|
| 24 |
Recommendation of IV Dose Preparation Practices Using Closed System Transfer Devices (CSTD) for Accurate Dosing
|
Liu, Qunhui
|
|
|
27 |
4 |
|
article
|
| 25 |
Removal of Excipients from Drug Product may Impact Antibody Characterization of Monoclonal Antibodies
|
Krishna, Kunal
|
|
|
27 |
4 |
|
article
|
| 26 |
Rethinking Pharmaceutical Industry with Quality by Design: Application in Research, Development, Manufacturing, and Quality Assurance
|
Duarte, Joana Galvão
|
|
|
27 |
4 |
|
article
|
| 27 |
Short-Term Immunosuppression in Rats Induces Prolonged Immune Tolerance Towards a Human Monoclonal Antibody, Erenumab
|
Gupta, Paridhi
|
|
|
27 |
4 |
|
article
|
| 28 |
Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study Data
|
Cleary, Yumi
|
|
|
27 |
4 |
|
article
|
| 29 |
Social Inequality and Antimicrobial Resistance: An Interconnected Global Problem
|
Vitiello, Antonio
|
|
|
27 |
4 |
|
article
|
| 30 |
The Reference-Corrected Visual Predictive Check: A More Intuitive Diagnostic for Non-Linear Mixed Effects Models
|
Ibrahim, Moustafa M. A.
|
|
|
27 |
4 |
|
article
|
| 31 |
The 100th Monoclonal Antibody Product is Approved in Japan
|
Hariu, Aya
|
|
|
27 |
4 |
|
article
|
| 32 |
The Use of Surrogate Matrix for Calibrators in the Analysis of Dried Blood Samples – A Feasibility Study
|
Lee, Dong Hun
|
|
|
27 |
4 |
|
article
|
| 33 |
TLR7-Adjuvanted Ionizable Lipid Nanoparticles for mRNA Vaccine Delivery
|
Misra, Bishal
|
|
|
27 |
4 |
|
article
|
Journal description